meglumine has been researched along with Central Nervous System Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colosimo, C; Enterline, DS; Martin, KW; Parmar, HA; Triulzi, FM | 1 |
| Essig, M | 3 |
| Maravilla, KR | 1 |
| Concepcion, R; Feuerstein, I; Marincola, F; Premkumar, A; Sanders, L; Schwartzentruber, D | 1 |
3 review(s) available for meglumine and Central Nervous System Neoplasms
| Article | Year |
|---|---|
Gadobenate dimeglumine-enhanced MR imaging of patients with CNS diseases.
Topics: Central Nervous System Neoplasms; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Molecular Structure; Organometallic Compounds | 2006 |
Gadobenate dimeglumine (MultiHance) in MR imaging of the CNS: studies to assess the benefits of a high relaxivity contrast agent.
Topics: Central Nervous System Neoplasms; Cerebrovascular Circulation; Clinical Trials, Phase II as Topic; Contrast Media; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Sensitivity and Specificity | 2005 |
MR imaging of CNS tumors: are all contrast agents created the same?
Topics: Central Nervous System Neoplasms; Contrast Media; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2006 |
3 other study(ies) available for meglumine and Central Nervous System Neoplasms
| Article | Year |
|---|---|
Safety and Diagnostic Efficacy of Gadobenate Dimeglumine in MRI of the Brain and Spine of Neonates and Infants.
Topics: Brain; Central Nervous System Neoplasms; Contrast Media; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Image Enhancement; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Reproducibility of Results; Retrospective Studies; Spine | 2019 |
Protocol design for high relaxivity contrast agents in MR imaging of the CNS.
Topics: Central Nervous System Neoplasms; Cerebrovascular Circulation; Contrast Media; Diagnosis, Differential; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Research Design | 2006 |
Visceral metastases from melanoma: findings on MR imaging.
Topics: Abdominal Neoplasms; Adult; Central Nervous System Neoplasms; Contrast Media; Drug Combinations; Eye Neoplasms; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Meglumine; Melanoma; Organometallic Compounds; Pentetic Acid; Soft Tissue Neoplasms | 1992 |